<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: New FDA guidance offers risks/rewards for industry</title>
	<atom:link href="http://blog.medadnews.com/index.php/2009/01/20/new-fda-guidance-offers-risksrewards-for-industry/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.medadnews.com/index.php/2009/01/20/new-fda-guidance-offers-risksrewards-for-industry/</link>
	<description>Just another WordPress weblog</description>
	<lastBuildDate>Mon, 23 Jan 2012 13:06:25 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: January 26th - 30th &#171; IPHA Press Review</title>
		<link>http://blog.medadnews.com/index.php/2009/01/20/new-fda-guidance-offers-risksrewards-for-industry/comment-page-1/#comment-3</link>
		<dc:creator>January 26th - 30th &#171; IPHA Press Review</dc:creator>
		<pubDate>Fri, 30 Jan 2009 13:26:11 +0000</pubDate>
		<guid isPermaLink="false">http://blog.medadnews.com/?p=23#comment-3</guid>
		<description>[...] revealed that earlier this month, FDA issued a final guidance on Good Reprint Practices, which will make it easier for pharmaceutical companies to advise doctors on unapproved uses of medicines.        [...]</description>
		<content:encoded><![CDATA[<p>[...] revealed that earlier this month, FDA issued a final guidance on Good Reprint Practices, which will make it easier for pharmaceutical companies to advise doctors on unapproved uses of medicines.        [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

